Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
3,84 USD | +1,32 % | +10,34 % | -82,52 % |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 50 | 14/07/21 | |
Director of Finance/CFO | 69 | 11/01 | |
Stuart Rich
CTO | Chief Tech/Sci/R&D Officer | 74 | 15/01/21 |
Doug Randall
COO | Chief Operating Officer | - | 14/11/13 |
Douglas Hay
LAW | General Counsel | - | 14/11/13 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Gerry Proehl
CHM | Chairman | 65 | 04/04/14 |
June Almenoff
BRD | Director/Board Member | 67 | 25/02/21 |
Declan Doogan
BRD | Director/Board Member | 72 | 25/02/21 |
Michael Davidson
BRD | Director/Board Member | 67 | 25/02/21 |
Robyn Hunter
BRD | Director/Board Member | 62 | 28/01/22 |
Stuart Rich
CTO | Chief Tech/Sci/R&D Officer | 74 | 15/01/21 |
Chief Executive Officer | 50 | 14/07/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 210 | 0 | 0 | 99,65 % |
Acción B | 1 | 1 958 245 | 1 951 298 ( 99,65 %) | 0 |
Información de la empresa
Tenax Therapeutics, Inc.
101 Glen Lennox Drive Suite 300
27517, Chapel Hill
+(919) 855-2100
http://www.tenaxthera.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-82,52 % | 7,52 M | |
+25,69 % | 47,86 mil M | |
+46,90 % | 41,42 mil M | |
-3,46 % | 40,66 mil M | |
-6,20 % | 28,92 mil M | |
+9,17 % | 25,55 mil M | |
-20,42 % | 19,27 mil M | |
+28,07 % | 12,14 mil M | |
+0,17 % | 12,15 mil M | |
-1,24 % | 11,99 mil M |
- Bolsa de valores
- Acciones
- Acción TENX
- Empresa Tenax Therapeutics, Inc.